FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783402384> ?p ?o ?g. }

• W2783402384 abstract "Naftopidil (NAF) is widely used for the treatment of benign prostatic hyperplasia and prevention of prostate cancer in elderly men. These patients receive a combination of drugs, which involves high risk for drug-drug interaction. Naftopidil exhibits superior efficacy but must be administered at a much higher dosage than other therapeutic drugs. We previously showed that extensive glucuronidation of naftopidil enantiomers caused poor bioavailability. However, the metabolic pathway and mechanism of action of naftopidil enantiomer remain to be elucidated. The present study was performed to identify the human UGTs responsible for the glucuronidation of NAF enantiomers and to investigate the potential inhibition of UGT activity by NAF. The major metabolic sites examined were liver and kidney, which were compared with intestine. Screening of 12 recombinant UGTs showed that UGT2B7 primarily contributed to the metabolism of both enantiomers. Moreover, enzyme kinetics for R(+)-NAF, UGT2B7 (mean Km, 21 μM; mean Vmax, 1043 pmol/min/mg) showed significantly higher activity than observed for UGT2B4 and UGT1A9. UGT2B4 (mean Km, 55 μM; mean Vmax, 1976 pmol/min/mg) and UGT2B7 (mean Km, 38 μM; mean Vmax, 1331 pmol/min/mg) showed significantly higher catalysis of glucuronidation of S(-)-NAF than UGT1A9. In human liver microsomes, R(+)-NAF and S(-)-NAF also inhibited UGT1A9: mean Ki values for R(+)-NAF and S(-)-NAF were 10.0 μM and 11.5 μM, respectively. These data indicate that UGT2B7 was the principal enzyme mediating glucuronidation of R(+)-NAF and S(-)-NAF. UGT2B4 plays the key role in the stereoselective metabolism of NAF enantiomers. R(+)-NAF and S(-)-NAF may inhibit UGT1A9. Understanding the metabolism of NAF enantiomers, especially their interactions with metabolic enzymes, will help to elucidate potential drug-drug interactions and to optimize the administration of this medicine." @default.
• W2783402384 created "2018-01-26" @default.
• W2783402384 creator A5001994950 @default.
• W2783402384 creator A5010848347 @default.
• W2783402384 creator A5019542186 @default.
• W2783402384 creator A5056093765 @default.
• W2783402384 creator A5062528520 @default.
• W2783402384 creator A5070704493 @default.
• W2783402384 creator A5072376242 @default.
• W2783402384 creator A5083234708 @default.
• W2783402384 creator A5084031452 @default.
• W2783402384 creator A5084455345 @default.
• W2783402384 date "2018-01-11" @default.
• W2783402384 modified "2023-10-15" @default.
• W2783402384 title "Human UDP-Glucuronosyltransferase 2B4 and 2B7 Are Responsible for Naftopidil Glucuronidation in Vitro" @default.
• W2783402384 cites W1499386625 @default.
• W2783402384 cites W1566094751 @default.
• W2783402384 cites W1576438855 @default.
• W2783402384 cites W1898202502 @default.
• W2783402384 cites W1973215369 @default.
• W2783402384 cites W1974905934 @default.
• W2783402384 cites W1985331805 @default.
• W2783402384 cites W1994696430 @default.
• W2783402384 cites W2001646009 @default.
• W2783402384 cites W2003123879 @default.
• W2783402384 cites W2022768595 @default.
• W2783402384 cites W2024913341 @default.
• W2783402384 cites W2027561440 @default.
• W2783402384 cites W2028976782 @default.
• W2783402384 cites W2040611122 @default.
• W2783402384 cites W2058843567 @default.
• W2783402384 cites W2083801378 @default.
• W2783402384 cites W2093289273 @default.
• W2783402384 cites W2097724546 @default.
• W2783402384 cites W2119970285 @default.
• W2783402384 cites W2142719287 @default.
• W2783402384 cites W2146743845 @default.
• W2783402384 cites W2149321951 @default.
• W2783402384 cites W2150854811 @default.
• W2783402384 cites W2351878066 @default.
• W2783402384 cites W2411878799 @default.
• W2783402384 cites W2519218656 @default.
• W2783402384 cites W2524833194 @default.
• W2783402384 cites W2593569079 @default.
• W2783402384 cites W2623484206 @default.
• W2783402384 cites W2766013563 @default.
• W2783402384 doi "https://doi.org/10.3389/fphar.2017.00984" @default.
• W2783402384 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5769128" @default.
• W2783402384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29375383" @default.
• W2783402384 hasPublicationYear "2018" @default.
• W2783402384 type Work @default.
• W2783402384 sameAs 2783402384 @default.
• W2783402384 citedByCount "5" @default.
• W2783402384 countsByYear W27834023842020 @default.
• W2783402384 countsByYear W27834023842021 @default.
• W2783402384 countsByYear W27834023842022 @default.
• W2783402384 crossrefType "journal-article" @default.
• W2783402384 hasAuthorship W2783402384A5001994950 @default.
• W2783402384 hasAuthorship W2783402384A5010848347 @default.
• W2783402384 hasAuthorship W2783402384A5019542186 @default.
• W2783402384 hasAuthorship W2783402384A5056093765 @default.
• W2783402384 hasAuthorship W2783402384A5062528520 @default.
• W2783402384 hasAuthorship W2783402384A5070704493 @default.
• W2783402384 hasAuthorship W2783402384A5072376242 @default.
• W2783402384 hasAuthorship W2783402384A5083234708 @default.
• W2783402384 hasAuthorship W2783402384A5084031452 @default.
• W2783402384 hasAuthorship W2783402384A5084455345 @default.
• W2783402384 hasBestOaLocation W27834023841 @default.
• W2783402384 hasConcept C126322002 @default.
• W2783402384 hasConcept C134018914 @default.
• W2783402384 hasConcept C181199279 @default.
• W2783402384 hasConcept C181389837 @default.
• W2783402384 hasConcept C185592680 @default.
• W2783402384 hasConcept C2777469378 @default.
• W2783402384 hasConcept C2779186261 @default.
• W2783402384 hasConcept C2779907587 @default.
• W2783402384 hasConcept C2781278898 @default.
• W2783402384 hasConcept C486523 @default.
• W2783402384 hasConcept C55493867 @default.
• W2783402384 hasConcept C62231903 @default.
• W2783402384 hasConcept C71240020 @default.
• W2783402384 hasConcept C71924100 @default.
• W2783402384 hasConcept C87644729 @default.
• W2783402384 hasConcept C98274493 @default.
• W2783402384 hasConceptScore W2783402384C126322002 @default.
• W2783402384 hasConceptScore W2783402384C134018914 @default.
• W2783402384 hasConceptScore W2783402384C181199279 @default.
• W2783402384 hasConceptScore W2783402384C181389837 @default.
• W2783402384 hasConceptScore W2783402384C185592680 @default.
• W2783402384 hasConceptScore W2783402384C2777469378 @default.
• W2783402384 hasConceptScore W2783402384C2779186261 @default.
• W2783402384 hasConceptScore W2783402384C2779907587 @default.
• W2783402384 hasConceptScore W2783402384C2781278898 @default.
• W2783402384 hasConceptScore W2783402384C486523 @default.
• W2783402384 hasConceptScore W2783402384C55493867 @default.
• W2783402384 hasConceptScore W2783402384C62231903 @default.
• W2783402384 hasConceptScore W2783402384C71240020 @default.
• W2783402384 hasConceptScore W2783402384C71924100 @default.
• W2783402384 hasConceptScore W2783402384C87644729 @default.
• W2783402384 hasConceptScore W2783402384C98274493 @default.

• next